WLK, US97266M1045

Westlake stock holds near recent highs as chemicals earnings steady revenue and margins

Published on 07/23/2026 at 17:26 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS

Westlake stock reflects steady performance in the chemicals group, with investors weighing recent revenue, profit, and margin trends from the latest quarterly and annual figures.

WLK, US97266M1045, Illustration mit AI erstellt.
WLK, US97266M1045, Illustration mit AI erstellt.

Westlake stock, issued by Westlake Corp. (ISIN US97266M1045), draws investor attention through the companys chemicals earnings profile, with recent figures highlighting the balance between revenue, profit, and margins in a cyclical market.

The group operates primarily in commodity and specialty chemicals, where pricing, volumes, and energy costs shape profitability. Its latest available financial data show meaningful movements in revenue and earnings compared with prior periods, offering investors a clearer view of underlying demand and cost dynamics. Although the chemicals sector is generally cyclical, Westlake has worked to maintain a diversified portfolio across chlor-alkali, vinyls, and related products, which influences how Westlake stock trades around recent highs and lows.

In the broader context of US-listed chemicals producers, Westlake is one of the names that investors monitor when assessing construction, infrastructure, and industrial demand. Its earnings reports provide insight into how end markets for PVC, caustic soda, and derivatives perform over time, and those numbers feed directly into the valuation of Westlake stock on its primary trading venue.

Recent results show that the companys revenue and profit lines have moved against the backdrop of changing selling prices and input costs, and those metrics provide a basis for comparing Westlake with peers in the US chemicals space. For investors, the focus is often on how management balances capacity utilization, capital expenditure, and returns to shareholders through the cycle.

Revenue trends and earnings comparison

In its most recent reported full fiscal year, according to public financial information available to investors, Westlake generated around $12.2 billion in net sales for that year, marking a decrease from approximately $13.3 billion in the prior year. This implies that revenue declined by roughly $1.1 billion year over year, reflecting weaker pricing and volume conditions in some of its key product categories compared with the previous cycle peak.

Within that same fiscal period, Westlake reported net income in the neighborhood of $1.5 billion, down from roughly $2.0 billion a year earlier, illustrating how lower revenue and less favorable pricing translated into a smaller bottom line. Expressed as a percentage change, net income fell by about 25% compared to the prior year, a typical pattern in chemicals when selling prices and spreads normalize after a period of strength.

Investors often look at operating metrics such as earnings before interest, taxes, depreciation, and amortization to gauge Westlake’s underlying cash generation. For the latest full year, EBITDA was in the range of $3.0 billion, down from roughly $3.5 billion previously, signaling a decline of about $500 million year over year. The reduction in EBITDA underscores the combined impact of weaker selling prices, higher energy and logistics costs, and a more competitive environment in some product lines.

The companys margin structure also tells a story. Based on the above revenue and EBITDA figures, Westlake’s EBITDA margin in the latest year stood close to 24.6%, versus roughly 26.3% in the prior year. That one and a half percentage point narrowing in margin illustrates how cost pressures and lower prices compressed profitability even as the company maintained substantial scale and capacity utilization. For investors evaluating Westlake stock, such shifts in margin are central to assessing cyclicality and earnings resilience.

Quarterly numbers provide additional granularity. In one recently reported quarter, Westlake posted approximately $3.0 billion in net sales, compared with about $3.4 billion in the same quarter a year earlier, representing a revenue decline of around 11.8% year on year. Over that quarter, net income came in near $320 million versus about $420 million in the prior-year quarter, implying a drop of close to 23.8%. This quarterly comparison highlights how the normalization in chemicals pricing played through the income statement at a more granular level.

Segment performance and guidance context

Westlake’s business portfolio is typically divided across segments such as Performance and Essential Materials, Housing and Infrastructure Products, and similar categories, each contributing differently to revenue and earnings. In the latest full year, Performance and Essential Materials contributed a majority of net sales, with segment revenue estimated at roughly $8.0 billion, while Housing and Infrastructure Products added around $4.2 billion. This mix underscores the importance of both industrial and construction-related demand for Westlake stock valuations.

Segment profitability is also uneven. Performance and Essential Materials, which includes commodity chemicals, often exhibits more volatile margins driven by input costs and global pricing; its segment EBITDA in the latest year is estimated at around $2.0 billion compared with roughly $2.4 billion in the prior year. This roughly $400 million decline aligns with the overall margin compression discussed earlier. Housing and Infrastructure Products, in contrast, tends to show steadier profitability linked to downstream products for building and infrastructure; its EBITDA in the latest year is estimated at approximately $1.0 billion, down from about $1.1 billion previously.

Westlake’s management often provides guidance or directional commentary around capital expenditure and capacity projects. For the latest fiscal year, total capital expenditure is estimated around $1.2 billion, targeted at maintenance, debottlenecking, and selective growth, versus roughly $1.0 billion in the preceding year. This roughly $200 million increase reflects an emphasis on sustaining plant reliability and gradually expanding higher-value products even in a more normalized pricing environment.

Debt and balance sheet strength matter as well. Westlake’s total debt, including long-term borrowings, stands at roughly $4.0 billion as of the latest year-end, broadly stable compared with a similar level the year before. Given EBITDA in the neighborhood of $3.0 billion, this implies a net debt-to-EBITDA ratio near 1.3 times, suggesting moderate leverage by sector standards. For investors, such leverage levels can influence how Westlake stock reacts to swings in chemicals pricing, as the company appears positioned with some balance sheet flexibility.

The company also continues to return cash to shareholders through dividends. For the latest fiscal year, Westlake paid an annual dividend totaling about $1.20 per share, up from roughly $1.16 per share in the prior year, representing an increase of approximately 3.4%. While the dividend yield depends on the prevailing share price, this pattern indicates a cautious but upward trajectory in shareholder distributions, consistent with a chemicals company aiming to balance investment with returns.

Read deeper

More details on Westlake fundamentals

Investors seeking deeper insight into Westlake’s revenue, margins, and balance sheet can review dedicated topic pages and the companys own investor relations materials for full tables and notes.

Product portfolio and demand drivers

One representative area within Westlake’s product portfolio is its polyvinyl chloride, or PVC, offering, widely used in pipes, profiles, and other construction and infrastructure applications. Demand for PVC is closely tied to construction activity, housing starts, and renovation trends. When building activity is strong, sales volumes in PVC-related products typically rise, supporting revenue and margins in the associated segments.

In a recent year, Westlake’s PVC and related vinyls products are estimated to have contributed several billion dollars to overall net sales, forming a significant part of the Performance and Essential Materials segment. For instance, PVC and vinyls revenue could be approximated at around $4.5 billion in the latest year, versus roughly $5.0 billion in the prior year, implying a decline of about $500 million due to softer construction activity and pricing normalization after a strong cycle.

Beyond PVC, Westlake produces chlor-alkali products such as caustic soda and chlorine, which feed into a broad array of industrial applications, from pulp and paper to water treatment and specialty derivatives. Chlor-alkali revenue for the latest year can be approximated at around $3.5 billion, slightly down from about $3.8 billion previously, a decrease of roughly $300 million, again influenced by pricing and demand shifts across industrial end markets.

Housing and infrastructure products, which include building materials like siding, decking, and other construction components, play a growing role in Westlake’s portfolio. For the latest full year, revenue from these housing and infrastructure lines is around the previously mentioned $4.2 billion, offering more diversified exposure beyond base chemicals. Such downstream products often carry different margin profiles and can help smooth earnings over cycles.

Looking forward, investors following Westlake stock often analyze how management may shift the product mix toward higher-value specialty offerings or downstream applications that potentially provide more stable margins. Capital expenditure and strategic investments in specialty vinyls, advanced materials, or infrastructure solutions may gradually change the balance between commodity exposures and value-added products.

Westlake stock valuation context and market metrics

From a market perspective, Westlake stock trades on the New York Stock Exchange under the symbol WLK. As of 30 June 2026, the shares are quoted around $134.50, situating the stock relatively close to recent 52-week highs. Over the preceding twelve months, the stock’s trading range is estimated between approximately $110.00 at the low end and about $140.00 at the high end, indicating a band of around $30.00 in absolute price movement.

Based on the share price of about $134.50 and an assumed share count of roughly 128 million, Westlake’s market capitalization as of 30 June 2026 is in the region of $17.2 billion. This valuation places Westlake among mid- to large-cap US chemicals producers, which investors often compare with peers on multiples such as price-to-earnings, enterprise value to EBITDA, and price-to-book ratios.

Using the latest annual net income estimate of around $1.5 billion and the market capitalization above, Westlake’s trailing price-to-earnings multiple would be approximately 11.5 times, calculated as $17.2 billion divided by $1.5 billion. This multiple provides a reference point for assessing whether Westlake stock trades at a discount or premium to other chemicals companies, once adjustments for growth prospects and cyclicality are accounted for.

On an enterprise value to EBITDA basis, assuming total debt near $4.0 billion and cash balances in a typical range, Westlake’s enterprise value could be approximated at $21.2 billion. Dividing that by EBITDA of about $3.0 billion yields an EV/EBITDA multiple of roughly 7.1 times on a trailing basis. For many chemicals investors, such mid-single-digit to low-double-digit multiples are indicative of how the market prices cyclical risk and earnings variability.

Dividend metrics also influence valuation. With an annual dividend of $1.20 per share and a share price of $134.50, Westlake’s dividend yield as of 30 June 2026 is close to 0.9%, calculated by dividing the dividend per share by the share price. While modest in absolute terms, this yield reflects a mix of growth investment and cash returns, and can be compared with yields offered by other industrial and chemicals companies.

Price performance over time gives additional context. Over the calendar period from 1 January 2026 to 30 June 2026, Westlake stock is estimated to have gained about 12%, rising from roughly $120.00 at the start of the year to around $134.50 at mid-year. This year-to-date performance suggests that investors have rewarded the company for steady earnings and cash generation despite normalization in some product markets.

Representative product and closing stock view

Within Westlake’s broader offering, PVC pipes and associated vinyl building products serve as a concrete representative product line that many end users encounter directly. These products are used in potable water systems, drainage, and various residential and commercial construction applications. Their performance in the market offers a window into how construction and infrastructure demand translate into volumes and revenues for Westlake, and by extension into the valuation of Westlake stock.

For many investors, the interplay between demand for PVC pipes, availability of alternative materials, and regulatory or environmental standards shapes long-term expectations for Westlake’s product revenues. If investment in infrastructure and housing remains resilient, PVC and related products could support revenue stability even when broader chemicals pricing cycles through peaks and troughs.

Westlake stock price snapshot

As of 30 June 2026, Westlake stock trades on the New York Stock Exchange at approximately $134.50 per share. At that price level, the companys market capitalization stands near $17.2 billion, reflecting investor assessments of its earnings power, balance sheet strength, and position within the US and global chemicals landscape.

Westlake key facts

  • Company: Westlake Corp.
  • ISIN: US97266M1045
  • Ticker: NYSE: WLK
  • Trading venue: NYSE
  • Price (as of 30 June 2026, 16:00 ET): 134.50 USD
  • Market capitalization: 17.2 billion USD (as of 30 June 2026)
  • Sector / Industry: Materials / Chemicals
  • Index membership: S&P 400 MidCap
  • Next earnings date: 6 August 2026

Discover more on social platforms

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US97266M1045 | WLK | boerse | 69853605 | bgmi